Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2026-03-02 @ 8:19 AM
Study NCT ID:
NCT00940758
Status:
COMPLETED
Last Update Posted:
2017-04-06
First Post:
2009-07-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I and Pharmacokinetic Study of Biweekly PEP02 in mCRC Refractory to 1st-line Oxaliplatin Base Therapy
Sponsor:
PharmaEngine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-06
Start Date Type:
ACTUAL
Primary Completion Date:
2012-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-06
Completion Date Type:
ACTUAL
First Submit Date:
2009-07-15
First Submit QC Date:
None
Study First Post Date:
2009-07-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-04
Last Update Post Date:
2017-04-06
Last Update Post Date Type:
ACTUAL